Not applicableStudy completedNCT05147571What this trial is testingRNS System NAUTILUS StudyWho this might be right forEpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure NeuroPace 100
Large-scale testing (Phase 3)WithdrawnNCT00175864What this trial is testingOpen Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.Who this might be right forEpilepsy UCB Pharma
Not applicableEnrolling By InvitationNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Not applicableLooking for participantsNCT06657378What this trial is testingEvaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic SeizuresWho this might be right forPartial-Onset SeizuresPrimary Generalized Tonic-clonic Seizures Eisai Co., Ltd. 110
Large-scale testing (Phase 3)Study completedNCT01393743What this trial is testingA Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic SeizuresWho this might be right forSeizure Disorder Generalized Tonic Clonic Eisai Inc. 163
Large-scale testing (Phase 3)Enrolling By InvitationNCT07287163What this trial is testingClinical Trial of Vormatrigine in Adult Patients With EpilepsyWho this might be right forEpilepsy, Tonic-ClonicFocal SeizurePrimary Generalized Seizure Praxis Precision Medicines 700
Not applicableLooking for participantsNCT07012148What this trial is testingOptimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and WearablesWho this might be right forFocal EpilepsyGeneralized SeizureDrug Refractory Epilepsy Mayo Clinic 12
Large-scale testing (Phase 3)Ended earlyNCT00692003What this trial is testingAdjunctive Zonisamide in Primary Generalised Tonic Clonic SeizuresWho this might be right forEpilepsy Eisai Limited 21
Large-scale testing (Phase 3)Study completedNCT02408549What this trial is testingSafety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic SeizuresWho this might be right forEpilepsy UCB BIOSCIENCES, Inc. 239
Post-approval studies (Phase 4)Study completedNCT00043901What this trial is testingTreatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New DrugWho this might be right forEpilepsy, Tonic-Clonic GlaxoSmithKline 141
Large-scale testing (Phase 3)Looking for participantsNCT06579573What this trial is testingONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.Who this might be right forEpilepsy, Generalized Ono Pharmaceutical Co., Ltd. 15
Large-scale testing (Phase 3)Study completedNCT00236704What this trial is testingThe Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresWho this might be right forEpilepsySeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Testing effectiveness (Phase 2)Study completedNCT03650452What this trial is testingA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesWho this might be right forEpilepsyDravet SyndromeLennox-Gastaut Syndrome Takeda 141
Testing effectiveness (Phase 2)Looking for participantsNCT07130786What this trial is testingProphylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain MetastasesWho this might be right forSeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more Ayal A. Aizer, MD 150
Testing effectiveness (Phase 2)Looking for participantsNCT06908356What this trial is testingAn Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic SeizuresWho this might be right forFocal Onset SeizurePrimary Generalized Epilepsy Praxis Precision Medicines 50
Large-scale testing (Phase 3)Study completedNCT00160550What this trial is testingStudy to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic SeizuresWho this might be right forGeneralized Convulsive Epilepsy UCB Pharma 154
Large-scale testing (Phase 3)Ended earlyNCT04485104What this trial is testingAssessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled SeizuresWho this might be right forSeizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet SyndromeSeizure in Participants With Lennox-Gastaut Syndrome Jazz Pharmaceuticals 3
Early research (Phase 1)Enrolling By InvitationNCT07262268What this trial is testingA Phase 1b Study of BHV-7000 in Participants With Inherited ErythromelalgiaWho this might be right forFamilial Erythromelalgia Biohaven Therapeutics Ltd. 5
Large-scale testing (Phase 3)Study completedNCT01463306What this trial is testingA 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic SeizuresWho this might be right forEpilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Not applicableStudy completedNCT04202159What this trial is testingEvaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic SeizuresWho this might be right forSeizures Eisai GmbH 187